A renaissance for SRC
The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This suggests that SRC activation may also be a dominant feature in CRC, which is supported by the observation that SRC activation was documented in > 80% of CRC [17].”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [17]
In the citing paper
“In response signaling from a variety of RTKs (including EGFR, HER2, HER4, PDGFR, VEGFR, FGFR4, GPCR, C-MET, IL-4/IL13/IL-13Rα2, IL-6ST/IL-6R/IL-11R), SRC has been reported to mediate diverse cell signaling pathways including RAS/MAPK (proliferation), PI3K/AKT (survival), FAK (adhesion/migration/EMT), and STAT3 (angiogenesis) [17, 49, 50].”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [17]
In the citing paper
“Aberrant SRC activation has been associated with a more aggressive phenotype and a worse prognosis in CRC patients [27, 28, 39].”
From Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer (2025) · cites this paper as [39]
In the citing paper
“The c-src is a non-receptor protein tyrosine kinase with a 60-kD molecular weight.It is a member of a 9-gene family named the Src family kinases (SFKs)”
From The molecular rationale of Src inhibition in colorectal carcinomas (2014) · cites this paper as [1]
Citations
Cites
Integrins: Versatility, modulation, and signaling in cell adhesion
Hynes, R. O. (1992) · Cell · doi:10.1016/0092-8674(92)90115-s · Cited by 9,859 · cited 1×
“Focal adhesions are also disassembled during transformation, during which the integrity of these structures is disrupted, permitting increased motilit”
BackgroundCell Migration: A Physically Integrated Molecular Process
Lauffenburger, D. A., & Horwitz, A. F. (1996) · Cell · doi:10.1016/s0092-8674(00)81280-5 · Cited by 3,915 · cited 1×
“This is followed by release of adhesions and retraction of the rear en”
BackgroundGiancotti, F. G., & Ruoslahti, E. (1999) · Science · doi:10.1126/science.285.5430.1028 · Cited by 3,869
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345 · cited 1×
“Although not yet reported for c- SRC , it has been possible to transform human fibroblasts with oncogenes such as HRAS when they are combined with human telomerase reverse transcriptase and the SV40 large T antige”
BackgroundTransforming gene product of Rous sarcoma virus phosphorylates tyrosine
Hunter, T., & Sefton, B. M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1311 · Cited by 2,332 · cited 1×
“v- src was subsequently shown to encode a tyrosine-specific protein kinas”
BackgroundThe STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278 · cited 1×
“STAT3 activation by v-Src has also been shown to contribute to other biological properties of cancer cells, including cell growth and survival, and tumour-cell immune evasio”
BackgroundFOCAL ADHESIONS, CONTRACTILITY, AND SIGNALING
Burridge, K., & Chrzanowska-Wodnicka, M. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.463 · Cited by 1,942 · cited 1×
“Small adhesions can transmit stong forces for rapid movement and ultimately mature into larger focal adhesion”
BackgroundReduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice
llić, D., Furuta, Y., Kanazawa, S., Takeda, N., Sobue, K., Nakatsuji, N., Nomura, S., Fujimoto, J., Okada, M., Yamamoto, T., et al. (1995) · Nature · doi:10.1038/377539a0 · Cited by 1,830
E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.
Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Löchner, D., & Birchmeier, W. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.1.173 · Cited by 1,551 · cited 1×
“Definitive studies in transgenic mice indicate that E-cadherin is an invasion suppresso”
BackgroundA causal role for E-cadherin in the transition from adenoma to carcinoma
Perl, A.-K., Wilgenbus, P., Dahl, U., Semb, H., & Christofori, G. (1998) · Nature · doi:10.1038/32433 · Cited by 1,424 · cited 1×
“and overexpression of E-cadherin can, in fact, counteract the acquisition of the invasive phenotyp”
Background
Cited by
Items 601–700 of 999
The Role of WAVE2 Signaling in Cancer
Rana, P. S., Alkrekshi, A., Wang, W., Markovic, V., & Sossey-Alaoui, K. (2021) · Biomedicines · doi:10.3390/biomedicines9091217 · Cited by 25
Rao, S., Larroque‐Lombard, A., Peyrard, L., Thauvin, C., Rachid, Z., Williams, C., & Jean‐Claude, B. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117215 · Cited by 29
Autophagic action of new targeting agents in head and neck oncology
Rikiishi, H. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.21079 · Cited by 26
Lin, R., Martyn, K. D., Guyette, C. V., Lau, A. F., & Warn‐Cramer, B. J. (2006) · Cell Communication & Adhesion · doi:10.1080/15419060600848516 · Cited by 25
“These stimulatory cell cycle effects are dependent on the PI 3-kinase and MAP kinase kinase (MEK) pathways (Riley et al. 2001; Yeatman 2004).”
BackgroundMariotti, M., Castiglioni, S., & Maier, J. A. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.08.017 · Cited by 29
“It is noteworthy that it is at the level of the membrane that activated Src interacts with several partners participating to the turnover of focal adhesions, an event which is necessary to allow cell migration [23].”
BackgroundTarget Points in Trastuzumab Resistance
Shojaei, S., Gardaneh, M., & Shamabadi, A. R. (2012) · International Journal of Breast Cancer · doi:10.1155/2012/761917 · Cited by 26
“SRC is activated upon phosphorylation that is catalyzed by protein tyrosine phosphatase alpha and SH-containing phosphatases SHP1/SHP2 [73].”
BackgroundArai, R., Tsuda, M., Watanabe, T., Ose, T., Obuse, C., Maenaka, K., Minami, A., & Ohba, Y. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.028 · Cited by 27
“Src family kinases (SFKs) are non-receptor tyrosine kinases that participate in numerous signalling pathways involved in proliferation, migration, adhesion and angiogenesis.(7,8) Elevated expression and/or activity of Src has been reported in a variety of human cancers (including those of the lung, breast, colon, pros…”
Csk regulates angiotensin II-induced podocyte apoptosis
Zhang, L., Ren, Z., Yang, Q., & Ding, G. (2016) · APOPTOSIS · doi:10.1007/s10495-016-1256-z · Cited by 25
Padhye, A., Ungewiss, C., Fradette, J. J., Rodriguez, B. L., Albritton, J. L., Miller, J. S., & Gibbons, D. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-41301-2 · Cited by 26
Yang, M., Davis, T. B., Pflieger, L., Nebozhyn, M. V., Loboda, A., Wang, H., Schell, M. J., Thota, R., Pledger, W. J., & Yeatman, T. J. (2022) · BMC Cancer · doi:10.1186/s12885-022-09344-3 · Cited by 22
“In response signaling from a variety of RTKs (including EGFR, HER2, HER4, PDGFR, VEGFR, FGFR4, GPCR, C-MET, IL-4/IL13/IL-13Rα2, IL-6ST/ IL-6R/IL-11R), SRC has been reported to mediate diverse cell signaling pathways including RAS/MAPK (proliferation), PI3K/AKT (survival), FAK (adhesion/migration/ EMT), and STAT3 (angi…”
BackgroundSelf-citationDual Drug Repurposing: The Example of Saracatinib
Ramos, R., & Vale, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084565 · Cited by 24
“…of Tyr419 in the catalytic domain leads to an open and active form of Src [1]. c-Src was the first protein kinase to be described as capable of phosphorylating tyrosine residues [26], being the most well researched member of the SFKs family and the most frequently involved in carcinogenesis [27].”
BackgroundJiang, Y., Xu, J., Huang, P., Yang, L., Liu, Y., Li, Y., Wang, J., Song, H., & Zheng, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.863756 · Cited by 27
Emerging Intrinsic Therapeutic Targets for Metastatic Breast Cancer
Li, J., Goh, E. L. K., He, J., Li, Y., Fan, Z., Yu, Z., Yuan, P., & Liu, D. (2023) · Biology · doi:10.3390/biology12050697 · Cited by 32
Fer tyrosine kinase oligomer mediates and amplifies Src-induced tumor progression
Oneyama, C., Yoshikawa, Y., Ninomiya, Y., Iino, T., Tsukita, S., & Okada, M. (2015) · Oncogene · doi:10.1038/onc.2015.110 · Cited by 23
Kumar, A., Wang, Y., Lin, X., Sun, G., & Parang, K. (2007) · ChemMedChem · doi:10.1002/cmdc.200700074 · Cited by 24
Mak, V. C. Y., Lee, L., Siu, M. K. Y., Wong, O. G., Lü, X., Ngan, H., Wong, E. S. Y., & Cheung, A. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt161 · Cited by 24
“variety of cancers and is associated with tumour metastasis [18].”
BackgroundTanji, M., Ishizaki, T., Ebrahimi, S., Tsuboguchi, Y., Sukezane, T., Akagi, T., Frame, M. C., Hashimoto, N., Miyamoto, S., & Narumiya, S. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00197-10 · Cited by 25
“their shape to the round refractile cell body (49).”
BackgroundRegulation of SRC Kinases by microRNA-3607 Located in a Frequently Deleted Locus in Prostate Cancer
Saini, S., Majid, S., Shahryari, V., Tabatabai, Z. L., Arora, S., Yamamura, S., Tanaka, Y., Dahiya, R., & Deng, G. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0017 · Cited by 24
“SRC, the prototypical member of SRC family kinases (41-43), is aberrantly activated in prostate cancer (17).”
Src nuclear localization and its prognostic relevance in human osteosarcoma
Urciuoli, E., Coletta, I., Rizzuto, E., Vito, R. D., Petrini, S., D'Oria, V., Pezzullo, M., Milano, G. M., Cozza, R., Locatelli, F., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26079 · Cited by 25
“Due to its proto-oncogene nature, Src is frequently associated with malignancy (Yeatman, 2004).”
BackgroundLy, T., Endo, A., Brenes, A. J., Gierliński, M., Afzal, V., Pawellek, A., & Lamond, A. I. (2018) · Wellcome Open Research · doi:10.12688/wellcomeopenres.14392.1 · Cited by 23
“The v-Src gene has played multiple paradigmatic roles in advancing our understanding of cell biology and disease mechanisms (Yeatman, 2004). v-Src was first discovered over a century ago as a viral oncogene that triggers cellular transformation and cancer malignancy in chicken cells (Rous, 1910).”
BackgroundJung, J., Ryu, S., Ki, I. A., Woo, H. A., & Lee, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061657 · Cited by 27
“Src kinase directly phosphorylates EGFR at Tyr 845 [69] and promotes cell adhesion, motility, and cancer development [70].”
BackgroundPark, S., Hwang, C. Y., Choi, J., Joung, C. Y., & Cho, K. (2020) · Oncogene · doi:10.1038/s41388-020-1255-y · Cited by 25
Yuan, G., Yao, M., Lv, H., Jia, X., Chen, J., & Xue, J. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01072 · Cited by 25
Gastrointestinal Hormones and Neurotransmitters
Liddle, R. A. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00001-9 · Cited by 25
Oncogene regulation of tumor suppressor genes in tumorigenesis
Sung, J. J. �. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh318 · Cited by 24
Ma, J., Huang, H., Chen, S.-M., Chen, Y., Xin, X., Lin, L., Ding, J., Liu, H., & Meng, L. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1302-4 · Cited by 27
“cellular processes, including cell proliferation, adhesion, migration, and invasion [1, 2].”
BackgroundRecent advances in pharmacological diversification of Src family kinase inhibitors
Negi, P., Cheke, R. S., & Patil, V. M. (2021) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-021-00172-x · Cited by 24
Kostić, A., Stojanov, S. J., Podolski-Renić, A., Nešović, M., Dragoj, M., Nikolić, I., Tasić, G., Schenone, S., Pešić, M., & Dinić, J. (2021) · Brain Sciences · doi:10.3390/brainsci11070884 · Cited by 24
“The deregulation of Src family tyrosine kinases (SFKs) activity is responsible for the growth and progression of various cancers [7], while elevated Src activity has been reported in GBM [8–10].”
BackgroundCell adhesion suppresses autophagy via Src/FAK-mediated phosphorylation and inhibition of AMPK
Zhao, M., Finlay, D., Kwong, E. M., Liddington, R., Viollet, B., Sasaoka, N., & Vuori, K. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110170 · Cited by 24
Qin, J., Guo, J., Tang, G., Li, L., & Yao, S. Q. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202218412 · Cited by 23
Kitazaki, H., Mori, T., Kang, J., Niidome, T., Murata, M., Hashizume, M., & Katayama, Y. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.08.028 · Cited by 23
Profiling Y561-Dependent and -Independent Substrates of CSF-1R in Epithelial Cells
Knowlton, M. L., Selfors, L. M., Wrobel, C. N., Gu, T., Ballif, B. A., Gygi, S. P., Polakiewicz, R. D., & Brugge, J. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013587 · Cited by 23
“activation of SFKs may contribute to tumor progression and lead to more aggressive tumor phenotypes [9].”
Targeting Src in endometriosis-associated ovarian cancer
Manek, R., Pakzamir, E., Mhawech-Fauceglia, P. Y., Pejovic, T. B., Sowter, H., Gayther, S. A., & Lawrenson, K. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.54 · Cited by 25
PTTG1 Levels Are Predictive of Saracatinib Sensitivity in Ovarian Cancer Cell Lines
Nakachi, I., Helfrich, B., Spillman, M., Mickler, E. A., Olson, C., Rice, J., Coldren, C. D., Heasley, L., Geraci, M. W., & Stearman, R. S. (2016) · Clinical and Translational Science · doi:10.1111/cts.12413 · Cited by 24
Teng, Y., Cai, Y., Pi, W., Gao, L., & Shay, C. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0485-0 · Cited by 24
“Regardless of which mechanism for Src activation, Src promotes numerous properties associated with metastatic potential once it is phosphorylated on tyrosine residues [12, 13].”
BackgroundThe Role of Kinase Signaling in Resistance to Bevacizumab Therapy for Glioblastoma Multiforme
Ramezani, S., Vousooghi, N., Joghataei, M. T., & Yousefzadeh-Chabok, S. (2019) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2018.2651 · Cited by 24
“98, 113–116 Evidently, a member of the SrcA subfamily pertaining SFKs called Yes constitutes a complex with the p85 regulatory subunit of PI3K to induce GBM cell invasion.”
α-Linolenic acid attenuates pseudo-allergic reactions by inhibiting Lyn kinase activity
Ding, Y., Wang, Y., Li, C., Zhang, Y., Hu, S., Gao, J., Liu, R., & An, H. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153391 · Cited by 25
A quantitative peptide array for evaluation of protein kinase activity
Han, X., Shigaki, S., Yamaji, T., Yamanouchi, G., Mori, T., Niidome, T., & Katayama, Y. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2007.09.026 · Cited by 23
Hikita, T., Oneyama, C., & Okada, M. (2010) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01439.x · Cited by 24
“Therefore, to analyze the mechanism of Src-mediated transformation, transformed cells expressing v-Src or a constitutively active form of c-Src with a mutation at the regulatory site (c-Src527F) were used (Yeatman 2004).”
BackgroundMethodInfluentialJiang, W., Xu, Z., Yu, L., Che, J., Zhang, J., & Yang, J. (2019) · Cell Biology International · doi:10.1002/cbin.11158 · Cited by 26
Manda, S., Lee, N. K., Oh, D., & Lee, J. (2020) · Molecules · doi:10.3390/molecules25081948 · Cited by 23
“Src, known as roto-oncogene tyrosine-protein kinase, is also associated with cancer cell survival and resistance to targeted anticancer therapies [33].”
BackgroundSignaling by the tyrosine kinase Yes promotes liver cancer development
Guégan, J., Lapouge, M., Voisin, L., Saba-El-Leil, M. K., Tanguay, P., Lévesque, K., Brégeon, J., Mes‐Masson, A., Lamarre, D., Haibe‐Kains, B., et al. (2022) · Science Signaling · doi:10.1126/scisignal.abj4743 · Cited by 23
“Dysregulated activity of SFKs is associated with the development and metastatic progression of cancer (39, 41, 42).”
BackgroundRecent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment
Masci, D., Naro, C., Puxeddu, M., Urbani, A., Sette, C., Regina, G. L., & Silvestri, R. (2023) · Molecules · doi:10.3390/molecules28227513 · Cited by 34
“SRC kinase mediates cell proliferation, growth, and survival [233], and its aberrant activation has been observed in breast cancers stemness [234] and metastasis [235].”
BackgroundTargeting the Rna-Binding Protein Sam68 As A Treatment For Cancer?
Lukong, K. E., & Richard, S. (2007) · Future Oncology · doi:10.2217/14796694.3.5.539 · Cited by 22
“Second, Src localized in perinuclear sites [37] may have easy access to nuclear Sam68.”
BackgroundKruewel, T., Schenone, S., Radi, M., Maga, G., Rohrbeck, A., Botta, M., & Borlak, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014143 · Cited by 23
“Both are c-Src mediated downstream targets of EGFR and crucial for tumour progression [33,34].”
Eguchi, R., Kubo, S., Takeda, H., Ohta, T., Tabata, C., Ogawa, H., Nakano, T., & Fujimori, Y. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs109 · Cited by 22
Microtubule and Actin Interplay Drive Intracellular c-Src Trafficking
Arnette, C. R., Frye, K. B., & Kaverina, I. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148996 · Cited by 22
Long non-coding RNA DLEU1 exerts an oncogenic function in non-small cell lung cancer
Zhang, S., Guan, Y., Liu, X., Ju, M., & Zhang, Q. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.175 · Cited by 22
Kumar, A., Ye, G., Wang, Y., Lin, X., Sun, G., & Parang, K. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060334k · Cited by 22
Lau, A. F. (2005) · Science s STKE · doi:10.1126/stke.2912005pe33 · Cited by 22
“Regulation of Gap Junction Permeability by SrcMediated Phosphorylation There has been renewed interest in understanding the precise functions of activated Src, the f irst oncoprotein to be discovered, and its substrates involved in cell proliferation, invasion, and motility (10, 11).”
BackgroundKang, C. W., Jang, K. W., Sohn, J., Kim, S., Pyo, K., Kim, I. H., Yun, M. R., Kang, H. N., Kim, H. R., Lim, S. M., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0350 · Cited by 23
“Instead, Src, as a common node downstream of multiple drug resistance pathways, might be activated by various signal inputs from specific RTKs, nonreceptor tyrosine kinases, or loss of protein tyrosine phosphatase activity (29, 31).”
BackgroundEffects of cerebrolysin on motor-neuron-like NSC-34 cells
Keilhoff, G., Lucas, B., Pinkernelle, J., Steiner, M., & Fansa, H. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.06.020 · Cited by 21
Clinical significance of Src expression and activity in human neoplasia.
Chatzizacharias, N. A., Kouraklis, G. P., Giaginis, C., & Theocharis, S. E. (2012) · PubMed · doi:10.14670/hh-27.677 · Cited by 26
“Several theories have been proposed about the sequence of events for the increased intrinsic Src activity observed (Summy and Gallick, 2003; Yeatman, 2004).”
BackgroundSrc inhibitors in suppression of papillary thyroid carcinoma growth
Henderson, Y. C., Toro–Serra, R., Chen, Y., Ryu, J., Frederick, M. J., Zhou, G., Gallick, G. E., Lai, S. Y., & Clayman, G. L. (2013) · Head & Neck · doi:10.1002/hed.23316 · Cited by 23
Contribution of phosphoproteomics in understanding SRC signaling in normal and tumor cells
Sirvent, A., Urbach, S., & Roche, S. (2015) · PROTEOMICS · doi:10.1002/pmic.201400162 · Cited by 22
“For instance, FAK, PI3K, STAT3, and Cortactin were found to be important SRC substrates for tumor cell growth and invasion [2, 26].”
BackgroundInfluentialTraenka, J., Hauck, C. R., Lewandrowski, U., Sickmann, A., Gambaryan, S. P., Thalheimer, P., & Butt, E. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-03-0143 · Cited by 21
“range of Src kinase substrates have been identified including focal adhesion proteins (FAK, Syk), adaptor proteins (cortactin) and transcription factors (STAT3) (27).”
BackgroundSrc Family Kinases Are Regulated in Multiple Myeloma Cells by Phosphatase of Regenerating Liver-3
Abdollahi, P., Vandsemb, E. N., Hjort, M. A., Misund, K., Holien, T., Sponaas, A.-M., Rø, T. B., Slørdahl, T. S., & Børset, M. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0212 · Cited by 17
“Overexpression and activation of SFK members promotes development of various human cancers (9, 10).”
Backgroundc-Src is required for hypoxia-induced metastasis-associated functions in prostate cancer cells
Dai, Y., & Siemann, D. W. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s201320 · Cited by 21
Greco, C., Taresco, V., Pearce, A. K., Vasey, C. E., Smith, S. J., Rahman, R., Alexander, C., Cavanagh, R. J., Musumeci, F., & Schenone, S. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00530 · Cited by 21
Role of Fyn Kinase Inhibitors in Switching Neuroinflammatory Pathways
Marotta, G., Basagni, F., Rosini, M., & Minarini, A. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867329666211221153719 · Cited by 25
Aten, T. M., Redmond, M., Weaver, S. O., Love, C. C., Joy, R. M., Lapp, A. S., Rivera, O. D., Hinkle, K. L., & Ballif, B. A. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.05.064 · Cited by 21
Kajiwara, K., Yamada, T., Bamba, T., Fukusaki, E., Imamoto, F., Okada, M., & Oneyama, C. (2013) · Biochemical Journal · doi:10.1042/bj20130527 · Cited by 21
Fu, S., Huang, Y.-J., Liang, F.-P., Huang, Y., Chuang, C.-F., Wang, S., & Yao, J.-W. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.045 · Cited by 21
Hu, J., Muller, K. A., Furnari, F. B., Cavenee, W. K., VandenBerg, S. R., & Gonias, S. L. (2014) · Oncogene · doi:10.1038/onc.2014.336 · Cited by 23
SRC inhibition represents a potential therapeutic strategy in liposarcoma
Sievers, E., Trautmann, M., Kindler, D., Huss, S., Gruenewald, I., Dirksen, U., Renner, M., Mechtersheimer, G., Pédeutour, F., Åman, P., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29645 · Cited by 21
“Dephosphorylation of tyrosine residue Tyr527 by phosphatases such as protein tyrosine phosphatase 1B (PTP1B) results in modulation of SRC conformation, the latter being a precondition for SRC activation by autophosphorylation of tyrosine residue Tyr416.(27) For instance, hepatocellular and colon carcinomas have been s…”
BackgroundNelson, L. J., Wright, H. J., Dinh, N. B., Nguyen, K. D., Razorenova, O. V., & Heinemann, F. S. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.10.017 · Cited by 23
Tyrosine phosphorylation of lamin A by Src promotes disassembly of nuclear lamina in interphase
Chu, C., Chen, Y.-H., Chiu, W., & Chen, H. (2021) · Life Science Alliance · doi:10.26508/lsa.202101120 · Cited by 21
“Src is a non-receptor protein tyrosine kinase that has been implicated in a wide variety of cellular functions, including cell proliferation, survival, and migration (Martin, 2001; Yeatman, 2004).”
BackgroundMitochondrial matrix-localized Src kinase regulates mitochondrial morphology
Lurette, O., Guedouari, H., Morris, J. L., Martín-Jiménez, R., Robichaud, J.-P., Hamel-Côté, G., Khan, M., Dauphinee, N., Pichaud, N., Prudent, J., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04325-y · Cited by 22
“It is involved in various physiological and oncogenic processes, ranging from metabolism, proliferation and differentiation to survival, motility and angiogenesis [8, 9].”
BackgroundmicroRNA-205 in prostate cancer: Overview to clinical translation
Chauhan, N., Manojkumar, A., Jaggi, M., Chauhan, S. C., & Yallapu, M. M. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188809 · Cited by 23
Temperini, M. E., Giacinto, F. D., Romanò, S., Santo, R. D., Augello, A., Polito, R., Baldassarre, L., Giliberti, V., Papi, M., Basile, U., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01693-2 · Cited by 22
“For this purpose, we exploited an n-acetyl-l-Cysteine (NAC) based treatment exerting an inhibitory effect on the activation of c-Src tyrosine kinase, a widely studied proto-oncogene, whose expression and activity is increased in several malignant conditions [57].”
MethodDai, W., Yang, J., Liu, X., Mei, Q., Peng, W., & Hu, X. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03822-8 · Cited by 20
“SRC family kinase is a key mediator of cellular tumor-promotion genic signals linked with tumor proliferation, migration, and invasion, and SRC could be activated in CRC through various mechanisms, including the regulations of the SRC-STAT3 signaling pathway, SRC-CTNNB1, and macro-autophagy/autophagy pathways [56, 57].”
BackgroundNoshita, S., Kubo, Y., Kajiwara, K., Okuzaki, D., Nada, S., & Okada, M. (2023) · Journal of Cell Science · doi:10.1242/jcs.261001 · Cited by 22
Zhao, W., Ouyang, C., Zhang, L., Wang, J., Zhang, Y., Zhang, Y., Huang, C., Xiao, Q., Jiang, B., Lin, F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51444-0 · Cited by 25
“The abnormal activation of c-SRC is prevalent in a wide array of human cancers, and its oncogenic effect makes it an attractive target for cancer treatment 29 .”
Lead acetate induces EGFR activation upstream of SFK and PKCα linkage to the Ras/Raf-1/ERK signaling
Wang, C.-Y., Wang, Y.-T., Tzeng, D.-W., & Yang, J. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.12.007 · Cited by 22
Wölfl, M., Schwinn, S., Yoo, Y.-E., Reß, M. L., Braun, M., Chopra, M., Schreiber, S. C., Ayala, V. I., Öhlén, C., Eyrich, M. K., et al. (2013) · Blood · doi:10.1182/blood-2013-03-488072 · Cited by 26
“It also inhibits src kinases, which are suitable targets in solid tumors.(1,2) However, src kinases are also expressed in nonmalignant cells, and their regulatory functions are diverse and not fully understood.”
BackgroundDrosophila C-terminal Src kinase regulates growth via the Hippo signaling pathway
Kwon, H. J., Waghmare, I., Verghese, S., Singh, A. P., Singh, A., & Kango‐Singh, M. (2014) · Developmental Biology · doi:10.1016/j.ydbio.2014.10.010 · Cited by 21
“Although Src expression is elevated in several tumors (Yeatman, 2004), Src overexpression in epithelial cells in flies is known to cause both proliferation and apoptosis (Vidal et al.”
BackgroundRadiation OncologyIn Vitro: Trends to Improve Radiotherapy through Molecular Targets
Feofanova, N. A., Geraldo, J. M., & de Andrade, L. M. (2014) · BioMed Research International · doi:10.1155/2014/461687 · Cited by 21
“Then, Src plays an important role in focal adhesion disassembly since its expression results in disruption of focal adhesions and stress fibers leading to the loss of adhesion to the extracellular matrix [128].”
BackgroundChhikara, B. S., Ashraf, S., Mozaffari, S., Jeans, N. S., Mandal, D., Tiwari, R. K., Ul‐Haq, Z., & Parang, K. (2020) · Molecules · doi:10.3390/molecules25092135 · Cited by 20
“Src family kinases (SFKs) have nine different PTKs, including c-Src, c-Yes, Fyn, Lck, Lyn, Hck, Frk, Blk, and c-Fgr of which Src is the prototype [1].”
BackgroundRao, V. K., Chhikara, B. S., Tiwari, R. K., Shirazi, A. N., Parang, K., & Kumar, A. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.10.124 · Cited by 20
Gueto, C., Ruiz, J. L. F., Torres, J. E., Méndez‐Hurtado, J., & Vivas‐Reyes, R. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.11.053 · Cited by 20
Roux, A. L., Busquets, M. A., Sagués, F., & Pons, M. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.11.013 · Cited by 20
Goel, R. K., Paczkowska, M., Reimand, J., Napper, S., & Lukong, K. E. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.000643 · Cited by 23
“Tyrosine Kinase, Src-related Kinase Lacking”
BackgroundInfluentialMicroRNAs as the fine-tuners of Src oncogenic signalling
Oneyama, C., & Okada, M. (2015) · The Journal of Biochemistry · doi:10.1093/jb/mvv036 · Cited by 20
“However, there are doubts whether v-Src demonstrates the intrinsic function of cellular Src (c-Src) because highly active v-Src induces aberrant phosphorylation of various proteins (3, 4).”
BackgroundInfluentialShimada, Y., Muneoka, Y., Nagahashi, M., Ichikawa, H., Tajima, Y., Hirose, Y., Ando, T., Nakano, M., Sakata, J., Kameyama, H., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39328-6 · Cited by 19
Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC Inhibitors
Beetham, H. G., Griffith, B. G. C., Murina, O., Loftus, A. E. P., Parry, D. A., Temps, C., Culley, J., Muir, M., Unciti‐Broceta, A., Sims, A. H., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0373 · Cited by 20
“It is not clear why bosutinib increases adhesion in the control cells as the reduction in adhesion observed with eCF506 is more consistent with the well documented role of SRC family kinases in cell–matrix adhesion (32).”
BackgroundFutosi, K., Németh, T., Horváth, Á. I., Abram, C. L., Tusnády, S., Lowell, C. A., Helyes, Z., & Mócsai, A. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221010 · Cited by 20
“Accordingly, Src-family kinases play major roles in diverse physiological and pathological processes such as hematological malignancies, cancer progression, platelet function, and immunity/inflammation (Yeatman, 2004; Zhang and Yu, 2012; Senis et al., 2014).”
Takahashi, R., Nagayama, S., Furu, M., Kajita, Y., Jin, Y., Kato, T., Imoto, S., Sakai, Y., & Toguchida, J. (2014) · Cancer Medicine · doi:10.1002/cam4.237 · Cited by 21
“The tyrosine kinase Src is a well-documented protein that causes cell rounding and enhances motility when activated [20].”
BackgroundBivalent Inhibitors of c-Src Tyrosine Kinase That Bind a Regulatory Domain
Johnson, T. K., & Soellner, M. B. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00243 · Cited by 22
Small‐Molecule Inhibition of the UNC119–Cargo Interaction
Mejuch, T., Garivet, G., Hofer, W., Kaiser, N., Fansa, E. K., Ehrt, C., Koch, O., Baumann, M., Ziegler, S., Wittinghofer, A., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201701905 · Cited by 24
Yu, M., Zou, Q., Wu, X.-X., Han, G., & Tong, X. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.09.065 · Cited by 19
SRC inhibition prevents P-cadherin mediated signaling and function in basal-like breast cancer cells
Ribeiro, A. S., Nobre, A. R., Mendes, N. M., Almeida, J., Vieira, A. F., Sousa, B., Carvalho, F. A., Monteiro, J., Polónia, A., Fonseca, M. B., et al. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0286-2 · Cited by 19
Hermida‐Prado, F., Villaronga, M. Á., Granda‐Díaz, R., Del-Río-Ibisate, N., Santos, L. M., Hermosilla, M. A., Oro, P., Allonca, E., Agorreta, J., Garmendia, I., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081157 · Cited by 19
“SRC is a pleiotropic non-receptor tyrosine kinase that interacts with multiple receptor tyrosine kinases and modulates multiple oncogenic signaling pathways [6,7], thereby regulating a variety of cellular processes central to the malignant phenotype, including proliferation, survival, cell-cell adhesion, motility, inv…”
BackgroundYu, L., Wang, L., Kim, J. E., Mao, C., & Shapiro, D. J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118765 · Cited by 20
Nešović, M., Rankov, A. D., Podolski-Renić, A., Nikolić, I., Tasić, G., Mancini, A., Schenone, S., Pešić, M., & Dinić, J. (2020) · Cancers · doi:10.3390/cancers12061570 · Cited by 24
“, epidermal growth factor receptor—EGFR), and integrins [7,16].”
BackgroundZhang, H., Shen, Z., Zhou, Y., Zhang, Z., Wang, Q., Zhang, M., Jiang, K., Wang, S., Ye, Y., & Wang, B. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.577948 · Cited by 20
“SRC family kinases (SFKs) are responsible for aggressive tumor proliferation, migration, and invasion in numerous malignancies (Yeatman, 2004).”
BackgroundGuedouari, H., Amer, Y. O., Pichaud, N., & Hébert-Chatelain, É. (2021) · Mitochondrion · doi:10.1016/j.mito.2020.12.012 · Cited by 21
Overexpression of Akt/PKB modulates N‐myristoyltransferase activity in cancer cells
Shrivastav, A., Varma, S., Senger, A., Khandelwal, R. L., Carlsen, S. A., & Sharma, R. K. (2009) · The Journal of Pathology · doi:10.1002/path.2550 · Cited by 24
“It is now well established that overexpression and/or activation of cSrc is linked to the development of several human cancers, especially those of the colon and breast [30,31].”
BackgroundAntitumor effects of Dasatinib on laryngeal squamous cell carcinoma in vivo and in vitro
Song, Y., Sun, X., Bai, W., & Ji, W. (2013) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-013-2394-3 · Cited by 20
“The non-receptor tyrosine kinase Src is known to promote cell proliferation, survival, and decreased adhesion, as well as increased motility, invasiveness, and angiogenesis, all of which promote the neoplastic phenotype [10].”
BackgroundIntracellular signalling and cancer: complex pathways lead to multiple targets
Bell, H. S., & Ryan, K. M. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.10.022 · Cited by 25
“These include numerous compounds designed to target the kinase domain of Src [100].”
BackgroundFu, Y., Yang, G., Xue, P., Guo, L., Yin, Y., Ye, Z., Peng, S., Qin, Y., Duan, Q., & Zhu, F. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0062-5 · Cited by 21
Metadata
- Authors
- Yeatman, T. J.
- Affiliations
- Moffitt Cancer Center (US)
- Corresponding author
- Yeatman, Timothy J.
- ORCID
- Yeatman, Timothy J.
- Venue
- Nature Reviews Cancer
- Published
- 2004-06-01
- Volume
- 4
- Issue
- 6
- Pages
- 470-480
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2036988959
- Cited by
- 1,113
- References
- 115
- Citations by year
- 2026: 17 · 2025: 21 · 2024: 20 · 2023: 43 · 2022: 43 · 2021: 46 · 2020: 44 · 2019: 39 · 2018: 49 · 2017: 44 · 2016: 69 · 2015: 56 · 2014: 72 · 2013: 79 · 2012: 73
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- Src kinase, non-receptor tyrosine kinase, cancer, metastasis, cell invasion, cell motility, cell proliferation, anticancer agents, tumor progression
- MeSH terms
- Antineoplastic Agents, Cell Division, Humans, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Phenotype, Gene Expression Regulation, Neoplastic, Genes, src, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.